Results 91 to 100 of about 54,158 (261)

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler   +8 more
wiley   +1 more source

Myocarditis Presenting as Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) in a Young Man: A Case Report

open access: yesActa Medica Indonesiana, 2023
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a unique disorder that manifests as an acute myocardial infarction clinically without overt coronary arteries obstruction on angiography.
Giovanni Reynaldo   +2 more
doaj   +2 more sources

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.

open access: yesArchives of medical science : AMS, 2013
Renal dysfunction is frequent in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Chronic kidney disease (CKD) is associated with very poor prognosis and is an independent predictor of early and late mortality and major bleeding in patients with NSTE-ACS.
Franczyk-Skóra, Beata   +3 more
openaire   +2 more sources

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy

open access: yesCardiologia Hungarica
In regularly updated myocardial infarction guidelines, infarctions, including non-ST-elevation myocardial infarction (NSTEMI), were classified into 5 etiological groups, but not all characteristic features of NSTEMI can be explained in all groups ...
Mihály Medvegy, Nóra Medvegy
doaj   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro   +15 more
wiley   +1 more source

The Etiological and Prognostic Value of Factor VIII in Patients Diagnosed with Myocardial Infarction: A Prospective Controlled Randomized Study

open access: yesEurasian Journal of Emergency Medicine
Aim: The purpose of this study was to evaluate the association between factor VIII (FVIII) and myocardial infarction. A comparative study was performed on patients diagnosed with acute myocardial infarction with/ non-ST-elevation myocardial infarction ...
Mevlana Gül   +3 more
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Non-ST Elevation Myocardial Infarction in the Setting of Multiple Open Frac-tures: A Case Report

open access: yesWMJ (Warmadewa Medical Journal)
Myocardial infarction (MI) generally occurs due to coronary atherosclerosis. However, under certain circumstances, trauma can act as a trigger for MI.
Made Ratih Santi Devinta   +1 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy